ClinicalTrials.Veeva

Menu

COvid Pandemic Institutional maNaGement (COPING)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Covid19

Treatments

Other: Tools development
Other: Quantitative analysis for Professionals
Other: Quantitative analysis for Patients
Other: Qualitative analysis for professionals

Study type

Observational

Funder types

Other

Identifiers

NCT04908007
69HCL20_0466

Details and patient eligibility

About

Covid-19 has increased organizational tensions within health services (lack of resources, difficulties in recruiting healthcare professionals , elderly and polypathological patients, etc.) and tested the reliability of health facilities. This project aims to draw lessons so that hospitals can transform themselves while improving their reliability to face future crises and other exceptional situations.

Research hypothesis:

Crisis management arrangements lack sensitivity to uncertainty, which manifests itself in lower quality of care and efficiency losses for the entire institution.

The virtuous practices implemented during the crisis spontaneously incorporated principles of the highly reliable organization.

The integration of principles from complexity theory into the management of institutions promotes high reliability organization.

Sustaining these virtuous practices in order to anticipate and cope with crises requires the activation of two interconnected levers: a shared vision (by patients, healthcare professionals, ARS, HAS, and the Ministry in the first place) of the meaning of the action taken by hospitals, and the development of a policy enabling hospitals to become both learning and highly reliable.

Main objective:

To evaluate the management process of the Covid-19 epidemic by the university hospitals of the Auvergne-Rhône-Alpes region, and the structures linked to them (establishments in their territory, ARS, user associations), in terms of points of improvement and good practices. This evaluation concerns the preparation, management and exit phases of the crisis.

Enrollment

20,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Establishments :

    • 4 university hospitals: Lyon, St Etienne, Clermont Ferrand, Grenoble
    • Establishments in the same territories, public and private
  • Professionals and members of the institutions' bodies:

    • Governance: management and chair of the CME
    • Management (care, communication, medical, technical, logistics, IT, personnel)
    • Clinical and public health cluster governance
    • Medical, paramedical and non-medical staff in the departments most concerned (emergency and EMS reception, intensive care, infectiology, hygiene, virology, imaging, occupational medicine in particular)
    • Organizations representing the personnel
    • Members of the users' representatives committee
  • Adult patients hospitalized for at least 48 hours during the study period (quantitative study by questionnaires).

Exclusion criteria

  • none

Trial design

20,000 participants in 4 patient groups

Professional qualitative group
Description:
Qualitative analysis of crisis management by interviewing professionals most involved during the crisis in each university hospital.
Treatment:
Other: Qualitative analysis for professionals
Professional quantitative group
Description:
Quantitative analysis of crisis management using the WHO grid adapted sent to the target persons identified within the establishments
Treatment:
Other: Quantitative analysis for Professionals
Patient quantitative group
Description:
Quantitative analysis of crisis management using a questionnaire sent to patients hospitalized in the first wave asking them about their perception of crisis and post-crisis management.
Treatment:
Other: Quantitative analysis for Patients
Tools development
Description:
Development of tools to prepare for situations of uncertainty
Treatment:
Other: Tools development

Trial contacts and locations

4

Loading...

Central trial contact

Julie HAESEBAERT, MD; Philippe MICHEL, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems